BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16505139)

  • 1. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.
    Boscardin SB; Hafalla JC; Masilamani RF; Kamphorst AO; Zebroski HA; Rai U; Morrot A; Zavala F; Steinman RM; Nussenzweig RS; Nussenzweig MC
    J Exp Med; 2006 Mar; 203(3):599-606. PubMed ID: 16505139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Fc Gamma Receptor IIIA Promotes Rather than Suppresses Humoral and Cellular Immune Responses after Mucosal or Parenteral Immunization with Antigen and Adjuvants.
    Sun JB; Holmgren J; Cragg MS; Xiang Z
    Scand J Immunol; 2017 Apr; 85(4):264-271. PubMed ID: 28128471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern-Recognition Receptor Agonist-Containing Immunopotentiator CVC1302 Boosts High-Affinity Long-Lasting Humoral Immunity.
    Du L; Hou L; Yu X; Cheng H; Chen J; Zheng Q; Hou J
    Front Immunol; 2021; 12():697292. PubMed ID: 34867941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.
    Hills T; Jakeman PG; Carlisle RC; Klenerman P; Seymour LW; Cawood R
    PLoS One; 2016; 11(11):e0166383. PubMed ID: 27861512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.
    Ochsenbein AF; Pinschewer DD; Sierro S; Horvath E; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13263-8. PubMed ID: 11069289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling Insufficiency.
    Gopalakrishnan A; Richard K; Wahid R; Harley R; Sztein MB; Hawkins LD; Vogel SN
    J Immunol; 2022 Nov; 209(10):1950-1959. PubMed ID: 36426935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Glycolipid-Peptide-Hapten Tricomponent Conjugate Vaccine Generates Durable Antihapten Antibody Responses in Mice.
    Pankhurst TE; Montgomerie I; Marshall A; Draper SL; Bilbrough T; Button KR; Palmer OR; Hermans IF; Painter GF; Connor LM; Compton BJ
    ACS Chem Biol; 2024 Jun; 19(6):1366-1375. PubMed ID: 38829263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B Cell Competition for Restricted T Cell Help Suppresses Rare-Epitope Responses.
    Woodruff MC; Kim EH; Luo W; Pulendran B
    Cell Rep; 2018 Oct; 25(2):321-327.e3. PubMed ID: 30304673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates target B cells to enhance humoral immune responses.
    Tonti E; Jiménez de Oya N; Galliverti G; Moseman EA; Di Lucia P; Amabile A; Sammicheli S; De Giovanni M; Sironi L; Chevrier N; Sitia G; Gennari L; Guidotti LG; von Andrian UH; Iannacone M
    Cell Rep; 2013 Oct; 5(2):323-30. PubMed ID: 24120862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Enrichment and Analysis of Antigen-Specific Memory B Cell Antibody Repertoires in PBMCs.
    Waltari E; McGeever A; Friedland N; Kim PS; McCutcheon KM
    Front Immunol; 2019; 10():1452. PubMed ID: 31293598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling effector functions of B cells during infection: the hidden world beyond antibody production.
    León B; Ballesteros-Tato A; Misra RS; Wojciechowski W; Lund FE
    Infect Disord Drug Targets; 2012 Jun; 12(3):213-21. PubMed ID: 22394173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and storage of inflammatory memory in barrier tissues.
    Ordovas-Montanes J; Beyaz S; Rakoff-Nahoum S; Shalek AK
    Nat Rev Immunol; 2020 May; 20(5):308-320. PubMed ID: 32015472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics.
    Wallace RP; Refvik KC; Antane JT; Brünggel K; Tremain AC; Raczy MR; Alpar AT; Nguyen M; Solanki A; Slezak AJ; Watkins EA; Lauterbach AL; Cao S; Wilson DS; Hubbell JA
    Cell Rep Med; 2024 Jan; 5(1):101345. PubMed ID: 38128533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers.
    Schiepers A; van 't Wout MFL; Hobbs A; Mesin L; Victora GD
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity alone does not drive long-lived plasma cell differentiation.
    McDougal CE; Pepper M
    Immunol Cell Biol; 2024 May; ():. PubMed ID: 38715314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen.
    Rampazo EV; Amorim KN; Yamamoto MM; Panatieri RH; Rodrigues MM; Boscardin SB
    PLoS One; 2015; 10(2):e0117778. PubMed ID: 25679777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen delivery to CD11c+CD8- dendritic cells induces protective immune responses against experimental melanoma in mice in vivo.
    Neubert K; Lehmann CH; Heger L; Baranska A; Staedtler AM; Buchholz VR; Yamazaki S; Heidkamp GF; Eissing N; Zebroski H; Nussenzweig MC; Nimmerjahn F; Dudziak D
    J Immunol; 2014 Jun; 192(12):5830-8. PubMed ID: 24829411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells: recent progress and open questions.
    Reizis B; Bunin A; Ghosh HS; Lewis KL; Sisirak V
    Annu Rev Immunol; 2011; 29():163-83. PubMed ID: 21219184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.
    Kraal G; Breel M; Janse M; Bruin G
    J Exp Med; 1986 Apr; 163(4):981-97. PubMed ID: 3950549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
    van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
    Front Immunol; 2018; 9():1997. PubMed ID: 30237798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.